The lengthy negotiation process with Medicare won't end until August 2024, with reduced prices going into effect in January 2026.
, which passed last year, empowered Medicare to negotiate drug prices for the first time in the program's six-decade history. The lengthy negotiation process won't end until August 2024, with reduced prices going into effect in January 2026.
Jardiance, made by Boehringer Ingelheim, is used to lower blood sugar for people with Type 2 diabetes.Januvia, made by, is used to treat Type 2 diabetes., is used to treat rheumatoid arthritis.Stelara, made by J&J subsidiary Janssen, is used to treat Crohn's disease.Many of the drugmakers contend that they had no real choice but to participate in the negotiations, specifically due to the penalties they could face if they choose not to.
That statement echoes the arguments outlined in at least nine separate lawsuits drugmakers filed against the Biden administration in recent months seeking to declare the negotiations unconstitutional. CMS will then make an initial price offer to manufacturers in February, and the companies have a month to accept or make a counteroffer.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Court strikes down federal rule that sharply increased prescription costs for many patientsDrugmakers’ copay assistance is at issue in patient-advocacy groups’ lawsuit.
続きを読む »
Cigna is paying over $172 million to settle claims over Medicare Advantage reimbursementHealth insurance provider The Cigna Group will pay more than $172 million over claims it gave the federal government inaccurate Medicare Advantage diagnoses codes in order to inflate reimbursement.
続きを読む »
Cigna to pay $172 million to settle charges it overcharged Medicare Advantage plansProsecutors alleged that Cigna submitted inaccurate and bogus codes for Medicare Advantage plans between 2016 and 2021.
続きを読む »
Cigna is paying over $172 million to settle claims over Medicare Advantage reimbursementHealth insurance provider The Cigna Group will pay more than $172 million over claims it gave the federal government inaccurate Medicare Advantage diagnoses codes in order to inflate reimbursement.
続きを読む »
U.S. to rein in technology that limits Medicare Advantage carePatients noticed that one tool often predicted a patient’s date of discharge that coincided with the date their insurer cut off coverage.
続きを読む »